Skip to Content
Medical Term:

anaplastic lymphoma kinase gene rearranged non-small-cell lung


A fusion protein resulting from the rearrangement of the EML4 gene with the ALK gene, present in approximately 5% of non-small-cell lung cancers, primarily adenocarcinomas. This fusion protein is a target of ALK tyrosine kinase inhibitors in the treatment of these tumors.

© Copyright 2017 Wolters Kluwer. All Rights Reserved. Review Date: Sep 19, 2016.